Viela Bio, Inc.
(NASDAQ GS: VIE)
Rigrodsky Law, P.A. is investigating Viela Bio, Inc. (“Viela”) regarding possible breaches of fiduciary duties and other violations of law related to Viela’s agreement to be acquired by Horizon Therapeutics plc. Under the terms of the agreement, Viela’s shareholders will receive $53.00 in cash per share.